Topics

Tumor-specific therapy targets ovarian cancer

19:00 EST 5 Nov 2019 | AAAS

(University of Connecticut) Nami Therapeutics, a collaboration by UConn and the University of North Carolina, is developing a tumor-specific radioactive therapy designed to specifically target ovarian cancer.

Original Article: Tumor-specific therapy targets ovarian cancer

NEXT ARTICLE

More From BioPortfolio on "Tumor-specific therapy targets ovarian cancer"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...